stockportfolio.pro
Drugs Made In America Acquisition II Corp. (DMII)
Financial Services · Shell Companies · NasdaqGM
Drugs Made In America Acquisition II Corp. revenue & earnings — last 1 fiscal years
| Metric | 2025 |
|---|---|
| Revenue | $0 |
| Gross profit | — |
| Net income | $4.19M |
| Net margin | — |
Source: Drugs Made In America Acquisition II Corp. SEC filings (10-K).
Explore 1 years of Drugs Made In America Acquisition II Corp. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track DMII in your portfolio →
Drugs Made In America Acquisition II Corp. financial history by metric
About Drugs Made In America Acquisition II Corp.
Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.
Drugs Made In America Acquisition II Corp. — frequently asked questions
What is Drugs Made In America Acquisition II Corp.'s revenue?
Drugs Made In America Acquisition II Corp. (DMII) reported revenue of $0 for fiscal year 2025, according to its SEC filings.
Is Drugs Made In America Acquisition II Corp. profitable?
Yes. DMII earned net income of $4.19M in fiscal 2025.
What is DMII's P/E ratio?
Drugs Made In America Acquisition II Corp. trades at a price-to-earnings ratio of about 72.0 based on the latest data in our nightly-refreshed cache.
How much debt does Drugs Made In America Acquisition II Corp. have?
As of fiscal year 2025, DMII carried roughly $0 in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Drugs Made In America Acquisition II Corp.'s market cap?
Drugs Made In America Acquisition II Corp. (DMII) has a market capitalization of about $642.10M, based on the latest data in our nightly-refreshed cache.
When does Drugs Made In America Acquisition II Corp.'s fiscal year end?
DMII's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
Where does this data come from?
All figures are computed from Drugs Made In America Acquisition II Corp.'s official SEC filings (10-K and 10-Q), covering 1 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.